Blueprint Medicines (NASDAQ:BPMC) reported 12/31/2018 earnings this Morning, coming in at ($1.83) per share, missing Wall Street’s estimates of ($1.68) per Share. Revenue for the quarter came in at $1.03 million missing the streets estimates of $1.77 million
Recent Trading for Blueprint Medicines (NASDAQ:BPMC)
Shares of Blueprint Medicines closed the previous trading session at with 75.5 shares trading hands.